Position in BHVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$270,711
New position
Shares Held
18,193
first reported quarter
Ownership
0.012%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#174
of 294 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Morgan Creek Capital Management, LLC holds $1,611,511 across 7 Biotechnology names. BHVN ranks #1 (16.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BHVN |
Biohaven Ltd.
This page
|
18,193 | $270,711 | |
| 2 | ACAD |
Acadia Pharmaceuticals Inc
|
9,395 | $237,693 | |
| 3 | MANE |
Veradermics, Inc
|
1,925 | $236,659 | |
| 4 | AVBP |
ArriVent BioPharma, Inc.
|
6,600 | $229,284 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
|
2,752 | $224,480 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
332 | $207,015 | |
| 7 | INSM |
INSMED Inc
|
1,929 | $205,669 |
All Filings in BHVN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $270,711 | 18,193 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||